Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapy
Authors:
- 1 March 2004
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 43 (3) , e10.1-e10.4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndromeKidney International, 2002
- Mycophenolate mofetil treatment for primary glomerular diseasesKidney International, 2002
- Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE)Pediatrics, 2000
- Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetilPediatric Nephrology, 2000
- Newer Immunosuppressive DrugsJournal of the American Society of Nephrology, 1999
- A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1998
- Successful mycophenolate mofetil treatment of glomerular diseaseAmerican Journal of Kidney Diseases, 1998